Stent Fracture after Everolimus-Eluting Stent Implantation
Compared with bare-metal stents, drug-eluting stents (DES) have greatly reduced the risk of in-stent restenosis (ISR) by inhibiting neointimal growth. Nevertheless, DES are still prone to device failure, which may lead to cardiac events. Recently, stent fracture (SF) has emerged as a potential mecha...
Saved in:
Main Authors: | Ali S. Almasood, Xavier Freixa, Sohail Q. Khan, Peter H. Seidelin, Vladimír Džavík |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.4061/2011/320983 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study
by: Hiroaki Matsuda, et al.
Published: (2020-01-01) -
Safety and efficacy of edoxaban monotherapy after bioabsorbable polymer everolimus-eluting stent implantation in a human-like coronary atherosclerotic porcine model
by: Daisuke Kitano, et al.
Published: (2025-03-01) -
Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model
by: Masayuki Mori, et al.
Published: (2020-01-01) -
Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅱ: Cell proliferation
by: Adam Peddle, et al.
Published: (2018-09-01) -
Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅰ: Drug transport
by: Tuoi Vo, et al.
Published: (2017-03-01)